Kincell Bio Appoints New Chief Executive Officer to Drive Business Growth
Mark, who has served as Chair of the Board since May 2024, brings decades of industry experience to the role and will be pivotal in advancing Kincell Bio’s mission to support innovators in the rapidly growing cell therapy sector.
CDMO | 21/01/2025 | By Aishwarya
Glenmark Life Sciences Rebrands its Identity as Alivus Life Sciences
The new identity, Alivus Life Sciences, represents vitality and growth with a renewed focus.
CDMO | 20/01/2025 | By Aishwarya | 206
OneSource Secures Equity Commitments of USD 95 Million for Fundraising
The strong interest from leading investors reflects growing confidence in our capabilities and the immense potential of the CDMO sector emerging out of India.
CDMO | 16/10/2024 | By Aishwarya
Agilent Announces Acquisition of BIOVECTRA
With the addition of BIOVECTRA, Agilent will expand its portfolio of CDMO services, add rapidly growing modalities, and bring world-class capabilities to support gene editing.
CDMO | 24/09/2024 | By Aishwarya | 197
Suven Pharmaceuticals Announces Appointment of Vivek Sharma as Executive Chairman
Vivek brings tremendous CDMO and leadership expertise to Suven, acquired across his roles as CEO of Piramal Pharma Solutions and as Chairman & CEO of Adare Pharma Solutions, a technology CDMO business (2020-22).
CDMO | 21/09/2024 | By Aishwarya | 155
LOTTE BIOLOGICS Announces Groundbreaking Ceremony for Songdo Bio Campus
LOTTE BIOLOGICS has announced to have held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International City.
CDMO | 04/07/2024 | By Aishwarya | 129
Formosa Laboratories Acquires Synchem to Expand in North America
Formosa Laboratories, Inc. has completed its acquisition of SynChem, Inc., a contract research laboratory located in suburban Chicago.
CDMO | 03/06/2024 | By Aishwarya | 203
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project
CDMO | 18/08/2023 | By Sudeep Soparkar | 296
Biovian chooses Elomatic to design ATMP cleanrooms in 6,400 sqm facility
Biovian chooses Elomatic to design ATMP cleanrooms in 6,400 sqm facility
CDMO | 16/08/2023 | By Sudeep Soparkar | 489
SK Pharmteco secures 12 global pharma clients sets up US R&D center
SK Pharmteco secures 12 global pharma clients, sets up US R&D center
CDMO | 09/08/2023 | By Sudeep Soparkar | 458
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy